Dementia detection just got a powerful upgrade with a groundbreaking dual approach that combines AI and patient input. This innovative method could revolutionize early diagnosis, especially in primary care settings where timely detection of Alzheimer's and related dementias has been a challenge.
The stigma surrounding dementia, limited time with patients, and the focus on immediate health concerns often lead to missed opportunities for early diagnosis. But here's where it gets controversial: researchers have developed a zero-cost, fully digital AI method that can be implemented across primary care clinics without adding to physicians' workload.
In a large-scale clinical trial involving over 5,000 patients, researchers from Regenstrief Institute and other esteemed institutions tested a dual approach. They combined the Quick Dementia Rating System (QDRS), a patient-reported tool, with an AI tool called a passive digital marker. This combination increased new dementia diagnoses by an impressive 31% compared to standard care, and it did so without requiring additional resources or costly tests.
The AI tool, developed over a decade by Regenstrief's Research Scientist Malaz Boustani, M.D., MPH, uses machine learning and natural language processing to analyze electronic health records. It identifies key indicators of dementia, such as memory issues and vascular concerns.
"This passive digital marker, built on over 50 years of digital health innovation, is now open source and available to all," Dr. Boustani explains. "It's a powerful tool that can be deployed at a low cost, similar to any app, and requires no licensing fees."
The dual approach not only increases detection rates but also leads to a 41% increase in follow-up diagnostic assessments, suggesting earlier and more accessible dementia care for underserved populations.
"This is a game-changer for early detection," Dr. Boustani emphasizes. "Most early detection methods are time-consuming and often come with costs. Our approach is unique because it requires no extra time or money from clinicians."
The trial, conducted at Eskenazi Health Centers in Indianapolis, seamlessly integrated the QDRS and passive digital marker into the Epic electronic health record system. Patients aged 65 and older were automatically invited to complete the QDRS survey through their patient portal, while the AI tool continuously analyzed their clinical data. Results were automatically flagged in clinicians' inboxes, prompting further evaluation only when necessary.
"This approach ensures that no one is left behind," says Zina Ben Miled, PhD, a Regenstrief affiliate scientist. "By embedding these tools into the health record, we can reach patients who might otherwise slip through the cracks, offering equal opportunities for early detection and care."
James E. Galvin, M.D., MPH, a professor at the University of Miami Miller School of Medicine, adds, "The Quick Dementia Rating System empowers patients and families to report cognitive changes easily. When combined with digital tools like the Regenstrief passive digital marker, we can scale early detection efforts efficiently."
This breakthrough demonstrates the potential of AI and patient-reported outcomes to transform clinical care. By integrating scalable digital tools into existing health systems, the research team has shown how technology can enhance early detection, reduce burdens on primary care teams, and improve outcomes for older adults.
"We're building on Regenstrief's legacy of using data and innovation to transform healthcare," Dr. Boustani concludes. "With this approach, we're bringing the power of AI and patient-reported outcomes into the clinic, seamlessly and affordably."
And this is the part most people miss: early detection is key to managing dementia and improving quality of life. With this innovative dual approach, we have a powerful tool to empower patients and families, and to ensure that no one is left behind in the fight against dementia.
